Search Our Website:
Jennifer R. Minter

Jennifer R. Minter


Pittsburgh, PA
  • Represented Longeveron Inc., a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, in its initial public offering and listing on the Nasdaq Capital Markets.
  • BodyMedia, a pioneer in developing and marketing wearable body monitors for consumers, in multiple equity financings, as well as its acquisition in August 2013 by Jawbone, a leader and innovator in human-centered wearable technology.
  • Clear Count Medical Solutions, a medical device start-up, in each of its equity and convertible debt financings since the Company’s inception in 2004.
  • Tandem Health Care, Inc., a provider of long-term health care services, in its $620 million sale to private equity firms JER Partners and Formation Capital, LLC.
  • Aethon Inc., a robot and software developer and manufacturer in the health care logistics industry, in its most recent debt and equity financings.
  • RTI International Metals, Inc. in its securities-related transactions prior to its acquisition, including its public offering of 6.9 million shares of common stock, $230 million Convertible Senior Note offering and $402.5 million Convertible Senior Note offering.
  • Ongoing representation of Dick's Sporting Goods in securities-related and corporate governance matters and transactions, including its acquisitions of Golf Galaxy (Nasdaq: GGXY) and Chick's Sporting Goods; its tender offer acquisition of Galyan's Trading Company (Nasdaq: GLYN); and its 144A Senior Convertible Notes Offering.
  • Cellumen, which delivers products and services that support drug discovery and development, in its Series B financing that included investments from Safeguard Scientifics, Inc. and PA Early Stage Partners.
  • International solar cell and printed electronics company Plextronics, Inc., in multiple equity and debt financing transactions with strategic partners as well as various venture capital firms and banks.
  • Represents multiple publicly-traded companies with respect to ongoing SEC and SRO compliance matters, including periodic reporting, annual meeting matters and related corporate governance practices.
  • Represents multiple medical cannabis companies, representing growers, processors and dispensaries, in corporate, financing and M&A matters, along with navigating the regulatory mazes associated with medical marijuana.